Víctor Manuel Becerra Muñoz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Víctor Manuel Becerra Muñoz has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Aranta Guzón-Rementería
Unidad de Gestión Clínica del Corazón, Hospital Virgen de la Victoria de Málaga, Málaga, Spain, Instituto Biosanitario Málaga (IBIMA), CIBERCV Málaga. Universidad de Málaga (UMA), Málaga, Spain.
1 shared publication - Carlos Porras-Martín
Unidad de Gestión Clínica del Corazón, Hospital Virgen de la Victoria de Málaga, Málaga, Spain, Instituto Biosanitario Málaga (IBIMA), CIBERCV Málaga. Universidad de Málaga (UMA), Málaga, Spain.
1 shared publication - Emiliano Andrés Rodríguez Caulo
Cardiovascular Surgery Department, Virgen de la Macarena University Hospital, Sevilla, Spain
1 shared publication - Encarnación Gutiérrez-Carretero
Servicio de Cirugía Cardiaca, Hospital Universitario Virgen del Rocío, Sevilla, España
1 shared publication - Gemma Sánchez-Espín
Unidad de Gestión Clínica del Corazón, Hospital Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga (IBIMA), Universidad de Málaga (UMA), CIBERCV Enfermedades Cardiovasculares, Málaga, Spain
1 shared publication - Jorge Rodríguez-Capitán
Instituto de Investigación Biomedica de Malaga y Plataforma en Nanomedicina (IBIMA Plataforma BIONAND), Malaga, Spain
1 shared publication
Latest Publications
- 8 October 2020
- Published by IMR Press in The Heart Surgery Forum
- Vol. 23 (6) , E763-E769
Outcomes of Isolated Tricuspid Valve Surgery
Background: Isolated tricuspid valve surgery is a rarely performed procedure and traditionally is associated with a bad prognosis, although its clinical outcomes still are little known. The aim of this study was to assess the short- and long-term clinical outcomes obtained at our center after isolated tricuspid valve surgery as treatment for severe tricuspid regurgitation. Methods: This retrospective study included 71 consecutive patients with severe tricuspid regurgitation who underwent isolated tricuspid valve surgery between December 1996 and December 2017. Perioperative and long-term mortality, tricuspid valve reoperation, and functional class were analyzed after follow up. Results: Regarding surgery, 7% of patients received a De Vega annuloplasty, 14.1% an annuloplasty ring, 11.3% a mechanical prosthesis, and 67.6% a biological prosthesis. Perioperative mortality was 12.7% and no variable was shown to be predictive of this event. After a median follow up of 45.5 months, long-term mortality was 36.6%, and the multivariate analysis identified atrial fibrillation as the only predictor (Hazard Ratio 3.014, 95% confidence interval 1.06-8.566; P = 0.038). At the end of follow up, 63.6% of survivors had functional class I. Conclusions: Isolated tricuspid valve surgery was infrequent in our center. Perioperative mortality was high, as was long-term mortality. However, a high percentage of survivors were barely symptomatic after follow up.
- 8 October 2020
- Published by IMR Press in The Heart Surgery Forum
- Vol. 23 (6) , E763-E769
Outcomes of Isolated Tricuspid Valve Surgery
Background: Isolated tricuspid valve surgery is a rarely performed procedure and traditionally is associated with a bad prognosis, although its clinical outcomes still are little known. The aim of this study was to assess the short- and long-term clinical outcomes obtained at our center after isolated tricuspid valve surgery as treatment for severe tricuspid regurgitation. Methods: This retrospective study included 71 consecutive patients with severe tricuspid regurgitation who underwent isolated tricuspid valve surgery between December 1996 and December 2017. Perioperative and long-term mortality, tricuspid valve reoperation, and functional class were analyzed after follow up. Results: Regarding surgery, 7% of patients received a De Vega annuloplasty, 14.1% an annuloplasty ring, 11.3% a mechanical prosthesis, and 67.6% a biological prosthesis. Perioperative mortality was 12.7% and no variable was shown to be predictive of this event. After a median follow up of 45.5 months, long-term mortality was 36.6%, and the multivariate analysis identified atrial fibrillation as the only predictor (Hazard Ratio 3.014, 95% confidence interval 1.06-8.566; P = 0.038). At the end of follow up, 63.6% of survivors had functional class I. Conclusions: Isolated tricuspid valve surgery was infrequent in our center. Perioperative mortality was high, as was long-term mortality. However, a high percentage of survivors were barely symptomatic after follow up.